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Abstract
Background: Resistance of the malaria parasite Plasmodium falciparum to sulfadoxine-pyrimethamine (SP) has evolved 
worldwide. In the archipelago of São Tomé and Principe (STP), West Africa, although SP resistance is highly prevalent 
the drug is still in use in particular circumstances. To address the evolutionary origins of SP resistance in these islands, 
we genotyped point mutations at P. falciparum dhfr and dhps genes and analysed microsatellites flanking those genes.
Methods: Blood samples were collected in July and December 2004 in three localities of São Tomé Island and one in 
Principe Island. Species-specific nested-PCR was used to identify P. falciparum infected samples. Subsequently, SNPs at 
the dhfr and dhps genes were identified through PCR-RFLP. Isolates were also analysed for three microsatellite loci 
flanking the dhfr gene, three loci flanking dhps and four loci located at putative neutral genomic regions.
Results: An increase of resistance-associated mutations at dhfr and dhps was observed, in particular for the dhfr/dhps 
quintuple mutant, associated with clinical SP failure. Analysis of flanking microsatellites suggests multiple independent 
introductions for dhfr and dhps mutant haplotypes, possibly from West Africa. A reduced genetic diversity and 
increased differentiation at flanking microsatellites when compared to neutral loci is consistent with a selective sweep 
for resistant alleles at both loci.
Conclusions: This study provides additional evidence for the crucial role of gene flow and drug selective pressures in 
the rapid spread of SP resistance in P. falciparum populations, from only a few mutation events giving rise to resistance-
associated mutants. It also highlights the importance of human migration in the spread of drug resistant malaria 
parasites, as the distance between the islands and mainland is not consistent with mosquito-mediated parasite 
dispersal.
Background
Resistance to virtually all classes of antimalarial drugs has
evolved in natural populations of Plasmodium falci-
parum, the human malaria parasite species responsible
for the great majority of malaria-attributed child mortal-
ity and morbidity. Resistance to chloroquine (CQ) is
prevalent in nearly all malaria-endemic regions, leading
to the discontinued use of this drug globally. Resistance to
sulfadoxine-pyrimethamine (SP), an affordable and
widely available alternative to CQ, has also spread rapidly.
Furthermore, therapeutic failure to the most recent
arteminisin combination therapies (ACTs) has been
reported in Southeast Asia [1].
Mutations in genes encoding dihydrofolate reductase
(dhfr) and dihydropteroate synthase (dhps) enzymes of
the parasite's folate pathway are associated with resis-
tance to pyrimethamine and sulfadoxine, respectively
[2,3]. Point mutations at codons 51, 59 and 108 of dhfr,
operate synergistically to enhance resistance to
pyrimethamine. The level of resistance is much higher in
a triple mutant N51I/C59R/S108N than in a single or
double mutant. Likewise, mutations at codons 437 and
540 of dhps increase the level of resistance to sulfadoxine,
with the double mutant A437G/K540E showing the high-
* Correspondence: jpinto@ihmt.unl.pt
1 UEI Malária & UEI Biologia Molecular, Centro de Malária e outras Doenças 
Tropicais, Instituto de Higiene e Medicina Tropical, Universidade Nova de 
Lisboa. Rua da Junqueira 100, 1349-008 Lisboa, Portugal
Full list of author information is available at the end of the articleSalgueiro et al. BMC Infectious Diseases 2010, 10:163
http://www.biomedcentral.com/1471-2334/10/163
Page 2 of 11
est level of resistance. Considering the two genes
together, the quintuple mutant N51I/C59R/S108N/
A437G/K540E accounts for clinical failure of SP [4].
As a result of the increased levels of resistance, SP has
been gradually removed from malaria control programs
worldwide. Nevertheless, selective pressure for SP-resis-
tant mutants persists, given the continued use of SP in
specific situations. Owing to its safety, SP is still recom-
mended for intermittent preventive therapy (IPT) in
pregnant women and children, even in regions where SP
efficacy for treatment of severe malaria is compromised
[5]. Also, an antifolate compound similar to SP,
trimethoprim-sulphamethoxazole, is suggested to pre-
vent opportunistic infections in HIV-infected patients in
developing countries [6]. Therefore, the origin and evolu-
tion of SP resistance remains a topic of both evolutionary
and epidemiological relevance. Furthermore, insights on
resistance to SP may also contribute to a better under-
standing of the evolutionary dynamics of resistance to
other drugs.
Roper et al. [7] presented evidence suggesting that the
dhfr triple mutant N51I/C59R/S108N occurring in South
Africa had a common ancestry with the Southeast Asian
triple mutant. Subsequent studies have shown that this
haplotype has spread throughout the African continent
and only very few local/regional haplotype variants of
African origin have been so far reported [8-12]. These
studies demonstrate also relatively few independent ori-
gins of double mutants at the dhfr gene, though greater
variation can be found in single mutants. Fewer studies
are available for the dhps gene but a recent continent-
wide study of Sub-Saharan African P. falciparum popula-
tions has shown that mutant dhps alleles have originated
from five independent geographically delimited ancestral
lineages: three for single mutants (A437G) and two for
double mutants (A437G/K540E) [13]. Collectively, the
above findings highlight that limited mutation events fol-
lowed by extensive gene flow have driven SP resistance in
P. falciparum populations worldwide. Interestingly, this
appears not to be the case in Plasmodium vivax for which
resistance-associated mutations at the dhfr  locus have
arisen from multiple independent mutation events in
Southeast Asia [14].
Selection of mutant parasites through drug pressure is
also a key factor for the rapid spread of SP resistance-
associated alleles. In a situation of marked selective pres-
sure acting on advantageous mutations at a locus, genetic
diversity tends to decrease and linkage disequilibrium
increases in the surrounding regions through genetic
hitchhiking. This process, also known as selective sweep,
c a n  b e  d e t e c t e d  b y  t h e  a n a l y s i s  o f  p u t a t i v e l y  n e u t r a l
genetic markers flanking the locus under selection at
increasing distances [15]. Using this approach, selective
sweeps of resistant dhfr  and  dhps  alleles have been
described for P. falciparum samples from Southeast Asia,
Africa and South America [10,16-18].
Until recently, CQ and SP remained respectively the 1st
and 2nd line therapeutic lines for malaria in the archipel-
ago of São Tomé and Principe (STP). However, the
increasing levels of both in vivo and in vitro resistance to
these antimalarials coupled with molecular surveys
pointing to high levels of resistance-associated mutations
[19-22], led to a change in the malaria therapeutic regime.
In the case of SP resistance genes, two reports point to an
increase of triple mutants N51I/C59R/S108N for the dhfr
gene [21,22]. In 2004, the STP government approved a
new antimalarial drug regime with artemisinin-based
combination therapies [23]. Since then STP has become
one of the few countries where the malaria burden was
reduced by 50% or more between 2000 and 2006-2007, in
line with WHO targets. Presently, SP is used in the
islands only for IPT during pregnancy. In 2007 the rate of
IPT use by pregnant women reached 76% [23], indicating
that selective pressure for SP-resistant mutants is still
present in STP.
In this context, the aims of the present study were: i) to
obtain a contemporary snapshot on the prevalence of
point mutations in the pfdhfr and pfdhps genes in natural
P. falciparum populations of STP; and ii) to investigate
the origin and evolutionary dynamics of these mutations,
by analysing microsatellite loci flanking these genes.
Results are interpreted with respect to the main evolu-
tionary forces driving SP resistance in the local P. falci-
parum  p o p u l a t i o n s ,  i n  l i g h t  o f  t h e  f a c t  t h a t  t h e s e  a r e
island populations, in which gene flow is likely to be more
restricted than in the mainland.
Methods
Study sites and sampling
The Democratic Republic of São Tomé and Príncipe
(STP) is located in the Gulf of Guinea, ca. 240 km off the
c o a s t  o f  G a b o n ,  W e s t  A f r i c a .  I t  c o m p r i s e s  t w o  m a i n
islands: São Tomé (859 km2) and Príncipe (142 km2), with
most of the 150,000 residents living in São Tomé. Malaria
reaches meso-hyperendemic levels and all four human
Plasmodium species are present in both islands, but with
large predominance of P. falciparum infections [24].
Blood samples were collected in July 2004 by finger
prick from children up to nine years-old, from three
localities of São Tomé - Neves (0°22'N; 6°32'E), Ribeira
Afonso (0°12'N; 6°43'E) and Angolares (0°4'N; 6°32'E), and
one from Príncipe - Rua dos Trabalhadores (1°38'N;
7°25'E). Collections were undertaken within the frame-
work of active-case malariological surveys carried out by
the Centro Nacional de Endemias, Ministry of Health of
STP. Ethical clearance was obtained from the Ministry of
Health of STP. Informed consent was obtained by the
parents or tutors of the children sampled. The localitiesSalgueiro et al. BMC Infectious Diseases 2010, 10:163
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of Neves and Angolares were sampled a second time, in
December 2004. Henceforward, these samples will be
referred to as Neves II and Angolares II, respectively.
Individual blood samples were spotted onto Whatman
No. 4 filter papers and kept dry at room temperature until
further processing.
DNA isolation, species identification and genotyping of 
dhfr and dhps
Blood spot samples were used to perform DNA extrac-
tion by a Chelex protocol [25]. Each DNA sample was
then used in a nested-PCR reaction, in order to identify
the presence of P. falciparum according to Snounou et al.
[26]. Using the PCR-RFLP method described by Durais-
ingh  et al. [27], parasite DNA was checked for Single
Nucleotide Polymorphisms (SNPs) at codons 51, 59 and
108 of the dhfr gene and at codons 437 and 540 of the
dhps gene.
Genotyping of microsatellite loci
In order to determine the evolutionary origins of dhfr and
dhps  haplotypes, we explored polymorphic microsatel-
lites flanking both genes, located 0.3 kb, 4.4 kb and 5.3 kb
upstream of codon 108 of dhfr (chromosome 4) and 0.8
kb, 4.3 kb and 7.7 kb downstream from codon 437 of dhps
(chromosome 8). A semi-nested PCR was performed for
each locus using the primers originally described by
Roper et al. [28] but with the primer modifications (i.e.
nucleotide extensions) suggested by Ndiaye et al. [11] for
the dhfr flanking microsatellites, to minimise stuttering.
PCR reactions and cycling conditions were as described
by Roper et al. [28]. Amplified fragments were separated
by capillary electrophoresis in an automatic sequencer
(ABI 3730, Applied Biosystems) at the Yale University
DNA Analysis Facility on Science Hill. Allele sizes were
scored using the software GeneMarker® (SoftGenetics).
As a reference, we have used the Southeast Asian P. falci-
parum K1 laboratory strain. This strain has a known mic-
rosatellite profile for the loci used that differs from the
widespread  dhfr  triple mutant lineage of Asian origin
(Roper C., pers. comm.). At microsatellites flanking the
dhps  gene, the allelic composition of the K1 strain
matches that of the East African dhps  double mutant
A437G/K540E haplotype lineage SGE 1 [13].
As suggested by McCollum et al. [10], we considered a
dhfr or dhps allele sensitive if it lacked drug resistance-
associated mutations within the coding region. The term
"haplotype" refers to a particular multilocus genotype
composed by the resistance-specific polymorphic locus
and the corresponding flanking microsatellite loci. Hap-
lotypes were differentiated if they contained one or more
allelic change across the loci. For haplotype reconstruc-
tion, we excluded all samples that failed to amplify in any
of the loci or that generated multiple peaks [28], in order
to avoid incorrect haplotype calling. For the remaining
analyses, if multiple peaks (alleles) were detected at any
locus, only the predominant allele (i.e. the peak with the
highest amplification intensity) was chosen as the repre-
sentative haplotype.
In order to obtain a measure of genetic variation and
linkage disequilibrium at putative neutral regions, we
genotyped further four microsatellite loci: TAA81 (chr.
5), PfPK2 (chr. 12), TAA109 and TAA87 (chr. 6). Primer
sequences and PCR conditions are described in [29,30].
PCR products were separated and scored as described
above. For each microsatellite locus, in cases where mul-
tiple peaks were present, only the value of the highest
peak was scored. The results derived from these neutral
markers were put in context with the patterns observed
in the microsatellites surrounding the dhfr  and  dhps
genes.
Statistical analysis
We assessed allelic richness (Rs), a measure of the number
of alleles independent of sample size, using FSTAT v. 2.9.3
[31]. The Microsoft® Office Excel Microsatellite tool kit
[32] was used to obtain allele frequencies for expected
heterozygosity (He) calculations. We calculated He as in
Anderson et al. [33]. Genetic differentiation per locus in
the total population sample was measured using an unbi-
ased estimator of FST [34] available in FSTAT. Linkage dis-
equilibrium (LD) was computed by exact tests of LD
available in GENEPOP v. 4.0 [35]. Initially, we compared
sulfadoxine-sensitive and resistant genotypes at the dhps
locus by defining subsamples as wild-type (or sensitive),
single mutant (A437G) or double mutant (A437G/
K540E). This approach was not implemented for the
pyrimethamine resistance-associated dhfr gene, because
we did not detect any wild-type individuals and the num-
ber of single mutants was extremely low. Therefore, we
could only compare triple mutants (N51I/C59R/S108N)
with double mutants (N51I/S108N). Corrections of the
nominal significance value (α = 0.05) to account for mul-
tiple testing were performed by a sequential Bonferroni
procedure [36].
Results
Point mutations at dhfr and dhps loci
Of the 934 blood samples analysed, approximately one
third (N = 326) were positive for P. falciparum. Table 1
describes the prevalence of wild-type, mutant and mixed
alleles infections for both dhfr and dhps genes, as well as
the corresponding genotypes. Allelic frequencies were
overall similar when comparing different sampling sites
and years.
For  dhfr, pyrimethamine resistance-associated muta-
tions N51I and S108N were extremely predominant














































































































Table 1: Allele and genotype frequencies of dhfr and dhps genes in Plasmodium falciparum of STP
Island Site Mutations Genotypes
dhfr dhps dhfr dhps dhfr/dhps
N51I C59R S108N A437G K540E WT single double triple WT single double quintuple
Príncipe Rua dos 
Trabalhadores
wild type 0.00 0.43 0.00 0.00 0.88
mutant 1.00 0.57 1.00 0.88 0.13 0.00 0.00 0.50 0.50 0.00 0.88 0.13 0.00
mixed 0.00 0.00 0.00 0.13 0.00
N 87 9 8 8 6 8 5
S. Tomé Ribeira Afonso wild type 0.00 0.36 0.00 0.05 0.90
mutant 0.97 0.56 0.97 0.82 0.05 0.00 0.00 0.32 0.68 0.05 0.86 0.10 0.18
mixed 0.03 0.08 0.03 0.14 0.05
N 29 25 29 22 21 19 21 11
Neves wild type 0.08 0.48 0.00 0.23 1.00
mutant 0.89 0.44 1.00 0.67 0.00 0.00 0.00 0.55 0.45 0.23 0.77 0.00 0.00
mixed 0.03 0.07 0.00 0.10 0.00
N 37 27 31 30 32 22 30 18
Neves II wild type 0.00 0.39 0.05 0.11 0.98
mutant 0.96 0.57 0.93 0.80 0.00 0.00 0.00 0.40 0.60 0.10 0.88 0.02 0.00
mixed 0.04 0.04 0.01 0.09 0.02
N 73 46 76 64 60 40 60 30
Angolares wild type 0.02 0.30 0.00 0.18 0.84
mutant 0.98 0.60 1.00 0.80 0.09 0.00 0.03 0.29 0.66 0.18 0.66 0.16 0.09
mixed 0.00 0.10 0.00 0.02 0.07
N 41 50 47 44 45 38 44 33
Angolares II wild type 0.00 0.18 0.03 0.07 0.78
mutant 1.00 0.73 0.93 0.89 0.21 0.00 0.00 0.20 0.80 0.07 0.71 0.22 0.19
mixed 0.00 0.08 0.04 0.04 0.02
N 63 60 71 55 58 50 55 32
STP All samples wild type 0.02 0.32 0.02 0.12 0.89
mutant 0.96 0.60 0.96 0.81 0.08 0.00 0.01 0.33 0.66 0.12 0.78 0.11 0.09
mixed 0.02 0.07 0.02 0.07 0.03
N 251 215 263 223 224 175 218 129
N: total number of alleles or genotypesSalgueiro et al. BMC Infectious Diseases 2010, 10:163
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tion. No wild-type genotypes were found and only one
sample harboured a single mutation. The triple mutant
N51I/C59R/S108N was present in 66% of the samples. As
for dhps, the most frequent point mutation was A437G
(81%). The double dhps mutant A437G/K540E appeared
in 11% of the samples. Eleven (9%) of the samples har-
boured the quintuple dhfr/dhps  mutant (N51I/C59R/
S108N/A437G/K540E), which is predictive of clinical
resistance to SP [4].
dhfr and dhps haplotype characterization
Haplotypes were characterized only in samples for which
no multiple infections were detected or that had not
failed PCR amplification in any of the loci. The frequency
of polyclonal infections was high, as expected from the
meso-hyperendemic levels of malaria transmission char-
acteristic of STP [24]. Consequently, our sample size was
considerably reduced for this analysis, with haplotypes
being reconstructed in 23 out of 175 genotyped isolates
for dhfr and in 9 out of 218 genotyped isolates for dhps.
For the dhfr gene, we detected five distinct haplotypes
classified as H1 to H5 according to the allele sizes at the
0.3 kb, 4.4 kb and 5.3 kb loci and the mutations carried
(Table 2). Three of these haplotypes were associated with
the triple mutant N51I/C59R/S108N and the two remain-
ing corresponded to double mutants N51I/S108N. Haplo-
types H2 and H3 had the same microsatellite
composition but carried double and triple dhrf  muta-
tions, respectively. The most abundant haplotype associ-
ated with the triple mutant (H5), consisting of 114bp/
183bp/210 bp at the 0.3 kb/4.4 kb/5.3 kb loci respectively,
has matching microsatellite sizes with the P. falciparum
K1 laboratory strain used as a control. W e did not find
any parasite carrying the wild-type allele at the three
point mutations of the dhfr gene, which precluded the
identification of haplotypes associated with
pyrimethamine sensitive parasites.
Regarding dhps, eight distinct haplotypes were detected
and classified as H1 to H8 according to allele sizes at 0.8
kb, and 4.3 kb and 7.7 kb loci (Table 3). Five haplotypes
Table 2: dhfr point mutations and their respective microsatellite haplotypes in allele size
Haplotype Point mutations Allele size (basepairs) N
Locus 0.3 kb Locus 4.4 kb Locus 5.3 kb
K1 C59R/S108N 114 183 210 -
H1 N51I/S108N 108 181 210 2
H2 N51I/S108N 108 183 200 10
H3 N51I/C59R/S108N 108 183 200 1
H4 N51I/C59R/S108N 108 183 210 1
H5 N51I/C59R/S108N 114 183 210 9
K1: reference isolate (see methods). N: number of isolates with the correspondent haplotype.
Table 3: dhps point mutations and their respective microsatellite haplotypes in allele size
Haplotype Point mutations Allele size (basepairs) N
Locus 0.8 kb Locus 4.3 kb Locus 7.7 kb
K1 A437G 131 103 108 -
H1 A437G 117 105 104 1
H2 A437G 117 105 106 1
H3 A437G 117 105 116 1
H4 A437G 117 109 134 1
H5 Wild type 123 103 110 1
H6 A437G 123 103 124 1
H7 A437G/K540E 131 103 108 2
H8 Wild type 133 117 110 1
K1: reference isolate (see methods). N: number of isolates with the correspondent haplotype.Salgueiro et al. BMC Infectious Diseases 2010, 10:163
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were associated with the single mutant A437G. The dhps
double mutant A437G/K540E was linked to haplotype H7
consisting of 131 bp/103 bp/108 bp at the 0.8 kb/4.3 kb/
7.7 kb loci respectively. This haplotype is an exact match
of the K1 control. Two haplotypes, H5 and H8, were asso-
ciated with wild type alleles.
Genetic variation and linkage disequilibrium
The effect of SP selection in the P. falciparum population
of STP was assessed by examining the levels of genetic
diversity, linkage disequilibrium and genetic differentia-
tion in the microsatellite loci flanking the dhfr and dhps
genes, in comparison with neutral loci. W e expected to
observe signatures of selection left by SP pressure in this
population [37], namely: i) a reduction in genetic diver-
sity around dhps and dhfr, due to a selective sweep; ii) an
increased genetic differentiation at the loci under selec-
tion; iii) significant LD between loci flanking dhps and
dhfr genes.
Overall, genetic diversity estimates at neutral loci (He =
0.82; Rs = 6.5; N = 308) were higher than at loci flanking
dhfr (He = 0.64; Rs = 4.6; N = 298) and dhps (He = 0.74; Rs =
5,1; N = 296) genes. For neutral loci, a low but significant
FST of 0.016 (P < 0.001) was obtained for the whole sample
subdivided according to collection sites, suggesting a rel-
atively shallow substructuring of P. falciparum popula-
tions among the localities surveyed. Differentiation was
however higher at flanking microsatellites, with FST val-
ues of 0.043 (P < 0.001) and 0.027 (P < 0.001) for dhfr and
dhps-linked loci, respectively.
In parasites harbouring dhfr  resistant alleles (double
and triple mutants), microsatellites flanking the dhfr gene
had lower genetic variation than neutral loci and loci
flanking the dhps gene (Table 4). Also, genetic differentia-
tion was higher at dhfr flanking loci, mainly attributed to
loci 0.3 kb (FST = 0.38) and 5.3 kb (FST = 0.57) when com-
pared to neutral loci (-0.01 ≤ FST ≤ 0.02) or to loci flanking
the dhps gene (-0.01 ≤ FST ≤ 0.01). The levels of genetic
diversity and differentiation were similar in neutral loci
and in loci flanking the dhps gene.
Microsatellite estimates for parasites carrying wild-
type or resistance-associated alleles at the dhps loci are
shown in Table 5. Mutant parasites, particularly double
mutants, presented lower levels of genetic diversity than
wild-type ones at flanking loci. Among wild-type alleles,
genetic diversity at flanking loci was comparable to that
observed for neutral loci. Genetic differentiation was
higher at loci that flanked the dhps gene (0.12 ≤ FST ≤
0.30) when compared to neutral (-0.01 ≤ FST ≤ 0.02) or
dhfr-linked (0.00 ≤ FST ≤ 0.01) loci.
Exact tests of linkage disequilibrium revealed three sig-
nificant associations between pairs of microsatellite loci
out of 92 tests performed with isolates carrying dhfr dou-
ble or triple mutants. Of these, there was a single signifi-
cant association between loci flanking the dhfr gene (loci
4.4 kb and 5.3 kb) that was found in the sample of double
mutants. For the dhps gene, there were 6 significant pair-
wise associations between microsatellite loci out of 135
tests. These were all detected in the group of single
mutants and there was also only a single significant asso-
ciation involving two microsatellites flanking the dhps
gene (loci 0.8 kb and 4.3 kb).
Discussion
When the results of the present study (collections in
2004) are interpreted in light of reports from surveys car-
ried out in 2000 [21] and in 2002 [22], a general trend
stands out for an increase in the frequency of mutant par-
asites, especially of dhfr triple mutants and dhps double
mutants. In 2000, the most common mutations found in
STP were N51I (92%) and S108N (95%) for dhfr, and
A437G (75%) for dhps [21]. Our present results support a
trend for fixation of the most common mutations at the
dhfr gene (96% for both N51I and S108N). Regarding the
dhps  gene, the proportion of A437G mutations here
reported (81%) is also higher than in 2000 (75%) but
lower than in 2002 (86%) [22]. In contrast, only 7% of P.
falciparum  isolates harboured the K540E mutation in
2000 [21] and none of the isolates carried this mutation in
2002 [22]. This could have been due to a smaller sample
size or a more restricted geographic sampling area in the
latter study. In the present dataset the frequency of the
dhps K540E was 11% (8% single + 3% mixed infections,
Table 1) and there was an increase of the double dhps
mutant A437G/K540E (2000: <7%; 2004: 11%), conse-
quently leading to a 2-fold rise of the dhfr+dhps quintuple
mutant (2000: 4%; 2004: 9%). The K540E mutation is only
seldomly found in West Africa [13]. In contrast, in East
Africa both the K540E allele and its associated quintuple
mutant have reached high prevalence and have been
shown to be robust predictors of SP clinical failure
[5,38,39]. Therefore, SP remains partially effective in
Central Africa possibly due to the still reduced frequency
of the K540E mutation. The observed increase in the
prevalence of the dhps K450E mutation and consequently
of the quintuple mutant in STP should thus be considered
a subject of concern.
In the present study, two distinct haplotypes were
found associated with the double mutant N51I:S1018N
and three were associated with the triple mutant
N51I:C59R:S1018N. In the triple mutants, the most
abundant haplotype, H5 (0.3 kb/4.4 kb/5.3 kb: 114 bp/183
bp/210 bp), is an exact match of the haplotype of the P.
falciparum K1 laboratory strain. This strain has a micro-
satellite profile that differs from the intercontinental
widespread triple mutant haplotype of Southeast Asian
origin (Roper C. pers. comm.). By reviewing the litera-Salgueiro et al. BMC Infectious Diseases 2010, 10:163
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ture, we found haplotypes very close to H5 in Senegal
(113 bp/183 bp/211), [11]). In addition, haplotype H4
(108 bp/183 bp/210 bp), that occurred once in our sam-
ple, nearly matches the Senegalese haplotype (109 bp/183
bp/211 bp) that was confirmed to be of Southeast Asian
origin [11]. Haplotype H3 is likely to have derived from
H4 by recombination or mutation as it differs only at the
most distal microsatellite locus (5.3 kb). However, the H3
t r i p l e  m u t a n t  m a y  a l s o  h a v e  a r i s e  f r o m  H 2  d o u b l e
mutants through an additional mutation occurring at
position 59 of the dhfr gene. Indeed, haplotype H2 shares
the same microsatellite profile as H3 and it was the most
frequent haplotype in double mutants. Taken together, it
appears that dhfr triple mutants in STP derive from two
independent lineages that were introduced in the islands
from continental Africa, although we cannot fully exclude
one additional independent local origin associated with
haplotype H3.
Similarly, microsatellite haplotype composition for the
dhps gene provides evidence for at least three indepen-
dent introductions of mutant parasites in STP. The only
dhps double mutant haplotype identified has a microsat-
ellite profile coincident with the SGE 1 lineage described
by Pearce et al. [13]. This double mutant lineage has orig-
i n a t e d  i n  E a s t  A f r i c a  w h e r e  i t  i s  t h e  m o s t  p r e v a l e n t
mutant lineage. In West Africa, the SGE 1 is rare but it
has been detect in a few West African countries, includ-
ing Gabon in the Gulf of Guinea [13]. In West Africa,
A437G single mutants prevail and three independent
ancestry lineages have been identified based on the two
microsatellites most proximal to the dhps gene, 0.8 kb
and 4.3 kb [13]. Using the same criterion, haplotypes H1,
H2 and H3 can be considered as representatives of the
AGK/SGK 1 lineage. This singl e  m u t a n t  l i n ea g e  i s  t h e
most prevalent in central and Southwest Africa, including
Angola, Congo and Gabon [13]. Haplotype H6 has a mic-
rosatellite profile closer to the AGK/SGK 3 lineage that
displays highest frequencies in countries bordering the
Gulf of Guinea such as Cameroon, Gabon, Ghana and
Nigeria [13]. Therefore, the haplotype composition of
dhps mutant parasites found in STP agrees with a sce-
nario of parasite introduction from neighbouring coun-
tries of the Gulf of Guinea.
As reported for other P. falciparum populations in con-
tinental Africa [10,13,17], the analysis of flanking micro-
satellites provided evidence of a selective sweep for both
dhfr and dhps resistant mutants. Reduced genetic diver-
sity and increased genetic differentiation was observed at
microsatellites flanking dhfr and dhps when compared to
neutral loci or when comparing resistant parasites with
Table 4: Allele richness (Rs), expected heterozygosity (He) and FST estimates at flanking and neutral microsatellites of P. falciparum dhfr 
double and triple mutants
dhfr genotypes
Microsatellites Double mutant (N = 52) Triple mutant (N = 99) all samples (N = 151)
Rs He Rs He Rs He FST P
Loci flanking dhfr gene Dhfr 0.3 8 0.34 7 0.68 9 0.51 0.38 <0.0001
Dhfr 4.4 8 0.48 6 0.45 7 0.46 -0.01 NS
Dhfr 5.3 6 0.35 6 0.37 7 0.36 0.57 <0.0001
All loci 7 0.39 6 0.50 8 0.44 0.37 <0.0001
Loci flanking dhps gene Dhps 0.8 12 0.67 10 0.53 13 0.60 0.01 NS
Dhps 4.3 8 0.70 7 0.67 8 0.69 0.01 NS
Dhps 7.7 14 0.92 15 0.90 17 0.91 -0.01 NS
All loci 11 0.76 11 0.70 13 0.73 0.00 NS
Neutral loci TAA81 8 0.83 11 0.84 10 0.83 0.02 NS
TA109 10 0.76 11 0.72 11 0.74 0.01 NS
TA87 11 0.89 12 0.85 12 0.87 0.01 NS
PfPK2 10 0.85 13 0.88 13 0.87 -0.01 NS
All loci 10 0.83 12 0.82 12 0.83 0.01 NS
N: Number of isolates genotyped. All loci: mean over loci Rs and He and global FST over loci as calculated by FSTAT. P: P-values of permutation tests 














































































































Table 5: Allele richness (Rs), expected heterozygosity (He) and FST estimates at flanking and neutral microsatellites of P. falciparum dhps genotypes
dhps genotypes
Microsatellites Wild type (N = 26) Single mutant (N = 154) Double mutant (N = 15) all samples (N = 195)
Rs He Rs He Rs He Rs He FST P
Loci flanking dhps gene Dhps 0.8 8 0.91 4 0.47 5 0.79 6 0.71 0.25 <0.0001
Dhps 4.3 6 0.85 4 0.53 3 0.26 4 0.55 0.30 <0.0001
Dhps 7.7 8 0.90 10 0.92 3 0.28 9 0.71 0.12 0.02
O v e r  a l l  l o c i 70 . 8 260 . 6 340 . 4 560 . 6 6 0 . 2 2 <0.0001
Loci flanking dhfr gene Dhfr 0.3 5 0.68 6 0.72 5 0.76 6 0.72 0.02 NS
Dhfr 4.4 4 0.49 5 0.44 2 0.13 5 0.36 <-0.01 NS
Dhfr 5.3 5 0.66 5 0.63 3 0.53 5 0.61 -0.01 NS
O v e r  a l l  l o c i 50 . 6 150 . 6 030 . 4 750 . 5 6 0 . 0 1N S
Neutral loci TAA81 7 0.84 7 0.83 6 0.83 7 0.83 0.01 NS
T A 1 0 9 60 . 7 480 . 7 740 . 5 080 . 6 7 0 . 0 1N S
T A 8 7 90 . 8 790 . 8 770 . 8 790 . 8 7 < 0 . 0 1N S
PfPK2 7 0.85 10 0.88 6 0.86 10 0.86 0.01 NS
O v e r  a l l  l o c i 70 . 8 390 . 8 460 . 7 790 . 8 1 0 . 0 1N S
N: Number of isolates genotyped. All loci: mean over loci Rs and He and global FST over loci as calculated by FSTAT. P: P-values of permutation tests to assess significance of FST values. NS: non-
significant (P > 0.05). In bold: significant after Bonferroni corrections for multiple tests.Salgueiro et al. BMC Infectious Diseases 2010, 10:163
http://www.biomedcentral.com/1471-2334/10/163
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wild type ones in the case of dhps. In the latter, this was
more evident for the case of double mutants. These data
correlate well with the trend for an increase of dhps dou-
ble mutants since 2000 [21], and consequently of dhfr/
dhps quintuple mutants.
Population structure could also contribute to the
observed patterns of differentiation at flanking loci, par-
ticularly if one takes into account that this study analysed
P. falciparum isolates from two islands. However, when
the samples were grouped according to collection site, the
FST estimate obtained for neutral loci, albeit significant,
was ca. two-fold lower than those observed for the micro-
satellites flanking dhfr and dhps genes. Moreover, low and
non-significant FST values were obtained for all neutral
microsatellites when samples were grouped according to
their genotypes at both genes. It is therefore unlikely that
the observed patterns of differentiation at flanking loci
result mainly from population subdivision.
In a scenario of a selective sweep acting on recently
introduced multiple haplotypes of a mutation under
selection (i.e. soft sweeps) one expects a strong LD signal
[40]. This is because introduced beneficial mutants carry-
ing new haplotypes cause the polymorphic sites to be in
complete LD. Unexpectedly, LD tests provided only weak
evidence of increased linkage, with a single significant
test for a locus pair at dhfr double mutants and another
for dhps single mutants. This observation may be attrib-
uted to the fact that SP-resistance in STP has been preva-
lent for quite sometime and, consequently, LD around
these loci has decayed over time due to the accumulation
of mutations and also to the effect of recombination
between haplotypes [40]. In STP, the first report of thera-
peutic failure to SP dates from 2000 [21], but positive
selection of mutant dhfr and dhps through drug pressure
most likely pre-dates this first finding. Being the 2nd line
for malaria treatment, one expects an increased usage of
SP since the early-1990's, when considerable levels of
resistance to the 1st line chloroquine had already been
reported [19]. Altogether these data point to an early
introduction of mutant parasites in STP, possibly during
the first half of the 1990's, which were subjected to selec-
tive pressure due to an already on-going increase of SP
usage in the islands. Presence of the dhfr triple mutant in
Cameroon was reported for the first time in 1985 [9]. The
emergence of dhps  m u t a n t s  i s  c o n s i d e r e d  t o  b e  m o r e
recent, but previous reports suggest that the emergence
of all mutant lineages, including the single mutants of
West African origin, may have occurred in the early- to
mid-1990's (see [13] and refs. therein). These time-scales
are in accordance with that here proposed for the intro-
duction mutant parasites in STP.
Conclusions
In spite of its geographical isolation, resistance to SP in P.
falciparum populations of STP islands has emerged from
multiple introductions of mutant parasites from the con-
tinent, possibly of West African origin. Once introduced
in the islands, resistance associated mutants have been
subjected to positive selection, resulting in a selective
sweep detectable at flanking microsatellites, due to the
increased usage of SP. As a consequence, it took little
more than a decade for resistant parasites to reach near
fixation frequencies. These findings reinforce the crucial
role of gene flow and strong selective pressures in the
rapid establishment of resistance to SP in P. falciparum
populations. They also highlight the importance of
human migration in the spread of drug resistant malaria
parasites, as the distance between islands and continent
should render mosquito-mediated parasite dispersal
unrealistic. Since 2004, a new ACT-based malaria treat-
ment regime was implemented in STP. The previous
experience with SP here reported makes a strong case for
a continuous monitoring of parasite susceptibility levels,
with particular focus on migrants and travellers from
endemic areas.
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